CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond

Significant progress has been achieved in the realm of therapeutic interventions for multiple myeloma (MM), leading to transformative shifts in its clinical management. While conventional modalities such as surgery, radiotherapy, and chemotherapy have improved the clinical outcomes, the overarching...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Abhinava K., Gupta, Ashna, Dagar, Gunjan, Das, Dayasagar, Chakraborty, Abhijit, Haque, Shabirul, Prasad, Chandra Prakash, Singh, Archana, Bhat, Ajaz A., Macha, Muzafar A., Benali, Moez, Saini, Kamal S., Previs, Rebecca Ann, Saini, Deepak, Saha, Dwaipayan, Dutta, Preyangsee, Bhatnagar, Aseem Rai, Darswal, Mrinalini, Shankar, Abhishek, Singh, Mayank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674477/
https://www.ncbi.nlm.nih.gov/pubmed/38006053
http://dx.doi.org/10.3390/vaccines11111721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674477/
https://www.ncbi.nlm.nih.gov/pubmed/38006053
http://dx.doi.org/10.3390/vaccines11111721

Ejemplares similares